ALPS Advisors’s Forma Therapeutics Holdings, Inc. Common Stock FMTX Stock Holding History

ALPS Advisors’s Portfolio FMTX Stock Details FMTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-26,147	Closed	-$522K	–	1112
2022 Q3	$522K	Sell	26,147 -2,212	-8%	-$29.2K	﹤0.01%	581
2022 Q2	$195K	Sell	28,359 -20,430	-42%	-$143K	﹤0.01%	999
2022 Q1	$454K	Sell	48,789 -6,066	-11%	-$64.6K	﹤0.01%	445
2021 Q4	$780K	Sell	54,855 -6,291	-10%	-$109K	0.01%	397
2021 Q3	$1.42M	Sell	61,146 -1,250	-2%	-$29.6K	0.01%	356
2021 Q2	$1.55M	Sell	62,396 -17,132	-22%	-$460K	0.01%	355
2021 Q1	$2.23M	Buy	79,528 +5,125	+7%	+$185K	0.02%	269
2020 Q4	$2.6M	Buy	+74,403	New	+$3.24M	0.03%	236

ALPS Advisors's FMTX Position: Q4 2022 in Review

ALPS Advisors sold out of Forma Therapeutics Holdings, Inc. Common Stock (FMTX) in Q4 2022, closing a stake of 26,147 shares — an estimated $522K sold.

ALPS Advisors first reported a position in FMTX in Q4 2020 and held it in 8 quarters. The position peaked at $2.6M in Q4 2020. 0 funds tracked by Wall St. Rank hold FMTX as of Q4 2022.

ALPS Advisors reported no remaining Forma Therapeutics Holdings, Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
ALPS Advisors sold 26,147 Forma Therapeutics Holdings, Inc. Common Stock shares in Q4 2022, an estimated $522K.
ALPS Advisors first reported a position in Forma Therapeutics Holdings, Inc. Common Stock in Q4 2020 and held it in 8 quarters.
ALPS Advisors's Forma Therapeutics Holdings, Inc. Common Stock position peaked at $2.6M in Q4 2020.
0 funds tracked by Wall St. Rank held Forma Therapeutics Holdings, Inc. Common Stock as of Q4 2022.

Based on ALPS Advisors's 13F filing for Q4 2022, filed 14 Feb 2023.